Reardon Tighe 4
4 · Janux Therapeutics, Inc. · Filed Nov 15, 2023
Insider Transaction Report
Form 4
Reardon Tighe
Acting Chief Financial Officer10% Owner
Transactions
- Purchase
Common Stock
2023-11-13$5.87/sh+849,854$4,988,643→ 849,854 total(indirect: See footnote)
Holdings
- 4,479,492(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]The shares are directly held by Avalon BioVentures I, LP (ABV I). Avalon BioVentures GP LLC (ABV GP) is a general partner of ABV I and may be deemed to have voting and investment power with respect to the shares held by ABV I and as a result may be deemed to have beneficial ownership of such shares. Mr. Reardon is a managing member of ABV GP and shares voting and investment power with respect to the shares held by ABV I. Mr. Reardon disclaims beneficial ownership of such shares except to the extent of his actual pecuniary interest therein, if any.
- [F2]The shares are directly held by Avalon BioVentures SPV I, LP (ABV SPV). ABV SPV I GP LLC (ABV SPV GP) is a general partner of ABV SPV and may be deemed to have voting and investment power with respect to the shares held by ABV SPV and as a result may be deemed to have beneficial ownership of such shares. Mr. Reardon is a managing member of ABV SPV GP and shares voting and investment power with respect to the shares held by ABV SPV. Mr. Reardon disclaims beneficial ownership of such shares except to the extent of his actual pecuniary interest therein, if any.